Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Explore ways to earn cash back on no annual fee cards. These strategies will help you maximize your savings and rewards.
23,562 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Investors are watching green brick (grbk) earnings closely to gauge the company’s growth trajectory and margin health...
As Alphabet shifts its advertising footprint and data strategy, Disney investors just really need to understand the p...
A practical guide to interpreting FRPH's Q2 2025 earnings transcript. Learn what to watch, how numbers fit the story,...
Markets rarely move in a straight line. This article analyzes the idea behind the prediction: trump bull market, what...
When Berkshire Hathaway named Greg Abel to lead investments, the portfolio made a surprising pivot. This article brea...
Three fintech names sit on the radar as potential acquisition targets in 2026. This analysis weighs market cap, cash ...
A well-known consumer stock has faced a sharp sell-off as markets wobble. This guide breaks down why the market punis...
A looming 10-year treasury signal could temper SCHD's 2026 rally as rising yields threaten valuations for dividend-fo...
Friday produced a meaningful price move for Simply Good Foods, but the story goes beyond a single day. This piece bre...
Five dividend-paying giants have sat on Goldman Sachs' Conviction List the longest, underscoring steady income as mar...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...